ReviewClinicoEconomics and outcomes research : CEOR2020

Analysis of the Cost-Effectiveness of Liquid Biopsy to Determine Treatment Change in Patients with Her2-Positive Advanced Breast Cancer in Colombia.

Diana Sánchez-Calderón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.